Literature DB >> 19455509

Power and sample size calculations for current status survival analysis.

John M Williamson1, Hung-Mo Lin, Hae-Young Kim.   

Abstract

Although sample size calculations have become an important element in the design of research projects, such methods for studies involving current status data are scarce. Here, we propose a method for calculating power and sample size for studies using current status data. This method is based on a Weibull survival model for a two-group comparison. The Weibull model allows the investigator to specify a group difference in terms of a hazards ratio or a failure time ratio. We consider exponential, Weibull and uniformly distributed censoring distributions. We base our power calculations on a parametric approach with the Wald test because it is easy for medical investigators to conceptualize and specify the required input variables. As expected, studies with current status data have substantially less power than studies with the usual right-censored failure time data. Our simulation results demonstrate the merits of these proposed power calculations. Copyright 2009 John Wiley & Sons, Ltd.

Mesh:

Year:  2009        PMID: 19455509     DOI: 10.1002/sim.3605

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  3 in total

1.  Urinary excretion of epidermal growth factor and rapid loss of kidney function.

Authors:  Jon Viljar Norvik; Laura R Harskamp; Viji Nair; Kerby Shedden; Marit D Solbu; Bjørn O Eriksen; Matthias Kretzler; Ron T Gansevoort; Wenjun Ju; Toralf Melsom
Journal:  Nephrol Dial Transplant       Date:  2021-09-27       Impact factor: 5.992

2.  Radiotherapy plus nimotuzumab or placebo in the treatment of high grade glioma patients: results from a randomized, double blind trial.

Authors:  Maria Teresa Solomón; Julio César Selva; Javier Figueredo; José Vaquer; Carolina Toledo; Nelson Quintanal; Silvia Salva; Rafael Domíngez; José Alert; Jorge Juan Marinello; Mauricio Catalá; Martha González Griego; Juan Antonio Martell; Patricia Lorenzo Luaces; Javier Ballesteros; Niurys de-Castro; Ferdinand Bach; Tania Crombet
Journal:  BMC Cancer       Date:  2013-06-19       Impact factor: 4.430

3. 

Authors:  Hélio Amante Miot
Journal:  J Vasc Bras       Date:  2017 Oct-Dec
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.